Completed PHASE2 INTERVENTIONAL 2-arm NCT00913484

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cocaine Dependence Opioid Dependency

Updated 6 times since 2017 Last updated: Nov 18, 2020 Started: Oct 31, 2000 Primary completion: Feb 29, 2004 Completion: Feb 29, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00913484, this PHASE2 trial focuses on Cocaine Dependence and Opioid Dependency and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 6 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Dec 2020 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Dec 2020 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States